These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 685891

  • 1. Effect of prednisone on growth and bone mineral content in childhood glomerular disease.
    Chesney RW, Mazess RB, Rose P, Jax DK.
    Am J Dis Child; 1978 Aug; 132(8):768-72. PubMed ID: 685891
    [Abstract] [Full Text] [Related]

  • 2. Bone mineral status measured by direct photon absorptiometry in childhood renal disease.
    Chesney RW, Mazess RB, Rose PG, Jax DK.
    Pediatrics; 1977 Dec; 60(6):864-72. PubMed ID: 600598
    [Abstract] [Full Text] [Related]

  • 3. Bone mineral content in nephrotic children on long-term, alternate-day prednisone therapy.
    Polito C, La Manna A, Todisco N, Cimmaruta E, Sessa G, Pirozzi M.
    Clin Pediatr (Phila); 1995 May; 34(5):234-6. PubMed ID: 7628164
    [Abstract] [Full Text] [Related]

  • 4. Longitudinal assessment of growth, mineral metabolism, and bone mass in pediatric Crohn's disease.
    Issenman RM, Atkinson SA, Radoja C, Fraher L.
    J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):401-6. PubMed ID: 8145096
    [Abstract] [Full Text] [Related]

  • 5. Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.
    Balsan S, Stéru D, Bourdeau A, Grimberg R, Lenoir G.
    Calcif Tissue Int; 1987 Jun; 40(6):303-9. PubMed ID: 3111667
    [Abstract] [Full Text] [Related]

  • 6. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
    Saggese G, Baroncelli GI, Bertelloni S, Perri G.
    J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
    [Abstract] [Full Text] [Related]

  • 7. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome.
    Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA.
    N Engl J Med; 2004 Aug 26; 351(9):868-75. PubMed ID: 15329424
    [Abstract] [Full Text] [Related]

  • 8. Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis.
    Lai HC, FitzSimmons SC, Allen DB, Kosorok MR, Rosenstein BJ, Campbell PW, Farrell PM.
    N Engl J Med; 2000 Mar 23; 342(12):851-9. PubMed ID: 10727589
    [Abstract] [Full Text] [Related]

  • 9. Delayed pubertal growth spurt and normal adult height attainment in boys receiving long-term alternate-day prednisone therapy.
    Polito C, La Manna A, Papale MR, Villani G.
    Clin Pediatr (Phila); 1999 May 23; 38(5):279-85. PubMed ID: 10349525
    [Abstract] [Full Text] [Related]

  • 10. Mineral loss in cortical and trabecular bone during high-dose prednisone treatment.
    Rickers H, Deding A, Christiansen C, Rødbro P.
    Calcif Tissue Int; 1984 May 23; 36(3):269-73. PubMed ID: 6432291
    [Abstract] [Full Text] [Related]

  • 11. Persistence of diminished bone mineral content following renal transplantation in childhood.
    Chesney RW, Rose PG, Mazess RB.
    Pediatrics; 1984 Apr 23; 73(4):459-66. PubMed ID: 6369239
    [Abstract] [Full Text] [Related]

  • 12. Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation.
    Aicardi G, Benso L, Vignolo M, Terragna A, Verrina E, Cordone G, Coppo R, Sernia O, Sardella ML, Di Battista E.
    Br J Rheumatol; 1993 May 23; 32 Suppl 2():39-43. PubMed ID: 8495279
    [Abstract] [Full Text] [Related]

  • 13. Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation.
    Broyer M, Guest G, Gagnadoux MF.
    J Pediatr; 1992 May 23; 120(5):721-5. PubMed ID: 1578306
    [Abstract] [Full Text] [Related]

  • 14. Effect of exogenous corticosteroid therapy on growth in children with HBsAg-negative chronic aggressive hepatitis.
    Clark JH, Fitzgerald JF.
    J Pediatr Gastroenterol Nutr; 1984 May 23; 3(1):72-6. PubMed ID: 6694051
    [Abstract] [Full Text] [Related]

  • 15. Growth of asthmatic children during treatment with alternate-day steriods.
    Reimer LG, Morris HG, Ellis EF.
    J Allergy Clin Immunol; 1975 Apr 23; 55(4):224-31. PubMed ID: 1123495
    [Abstract] [Full Text] [Related]

  • 16. Growth following renal transplantation in children and adolescents.
    Hoda Q, Hasinoff DJ, Arbus GS.
    Clin Nephrol; 1975 Jan 23; 3(1):6-9. PubMed ID: 165024
    [Abstract] [Full Text] [Related]

  • 17. Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids.
    Chesney RW, Mazess RB, Hamstra AJ, DeLuca HF, O'Reagan S.
    Lancet; 1978 Nov 25; 2(8100):1123-5. PubMed ID: 82684
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral content, corrected for height or bone area, measured by DXA is not reduced in children with chronic renal disease or in hypoparathyroidism.
    Ahmed SF, Russell S, Rashid R, Beattie TJ, Murphy AV, Ramage IJ, Maxwell H.
    Pediatr Nephrol; 2005 Oct 25; 20(10):1466-72. PubMed ID: 16047218
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment.
    Als OS, Christiansen C, Hellesen C.
    Clin Rheumatol; 1984 Jun 25; 3(2):201-8. PubMed ID: 6467862
    [Abstract] [Full Text] [Related]

  • 20. Alternate-day corticosteroid therapy in juvenile chronic polyarthritis.
    Ansell BM, Bywaters EG.
    J Rheumatol; 1974 Jun 25; 1(2):176-86. PubMed ID: 4457641
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.